Sort by
Refine Your Search
-
, immunology, molecular biology, proteomics, animal modeling and mouse genetics, translational medicine, and/or the use of human tumor models of cancers. Develops, adopts and implements new laboratory methods
-
with conducting analysis with different types of data, including metagenomics sequencing, genomics, proteomics and metabolomics data A good command of written and spoken English Strong communication
-
scientific research and offers innovative academic education to more than 20 000 students. With over 6000 employees from 100 different nationalities, we provide an international working environment
-
cancer cells utilizing different novel metabolic techniques. Minimum Qualifications MD or Ph.D. in Basic Science, Health Science, or a related field. No experience required. Preferred Qualifications PhD in
-
. This project will be implemented due to the joint forces of three laboratories from three different countries: Poland, Switzerland, and Germany, and three different leading specializations: RNA biology
-
for embryo selection. Objectives Our 2 main objectives are: 1/ improve media formulation to improve developmental speed of all embryos 2/ perform proteomics analysis of human embryos and spent culture
-
, and bioprotection, including culture selection and process optimization. Establish and apply proteomics-based workflows to characterize protein mixtures and proteolytic events (peptide/protein profiling
-
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt | Stein bei N rnberg, Bayern | Germany | about 1 month ago
differences in cancers. The method is used to identify cancer clones in melanoma cases and support clinical decisions with deep molecular analysis of the detected tumor clones. The postdoc (f/m/x) will build
-
disorders characterized by progressive muscle degeneration, yet different muscle groups are affected to varying degrees. This project explores a novel therapeutic concept: that the regenerative fate of muscle
-
pathology to resolve single cell heterogeneity and identify subtle cellular differences in cancers. The method is used to identify cancer clones in melanoma cases and support clinical decisions with deep